23andMe Holding Co. has announced the release of a new report on homocysteine levels for its 23andMe+ Premium members, coupled with an optional blood test available for an additional fee. This report ...

In a major leap for genetic diagnostics, scientists from the University of Melbourne and the Murdoch Children’s Research Institute (MCRI) have developed a groundbreaking rapid blood test that can ...

A blood test clarifies which gene variants truly cause congenital heart defects, linking diagnosis to more precise ...

Add Yahoo as a preferred source to see more of our stories on Google. A groundbreaking blood test promises to transform the diagnosis of rare genetic diseases in babies and children, offering results ...

Myriad Genetics, Inc. has announced the early access launch of its FirstGeneTM Multiple Prenatal Screen, which provides a comprehensive prenatal genetic risk assessment through a single blood draw, ...

Yesterday, the U.S. Food and Drug Administration approved the first blood-based genetic test that can detect gene mutations in non-small cell lung cancer patients. The cobas EGFR Mutation Test v2 is a ...

Milan, Italy: A new, rapid testing method will greatly help the diagnosis of rare diseases in babies and children, according to research to be presented to the annual conference of the European ...

A large-scale proteogenomic study uncovers key proteins and immune pathways that may drive asthma risk and severity—paving the way for targeted, personalized therapies. Study: Integration of ...

Add Yahoo as a preferred source to see more of our stories on Google. In a major leap for genetic diagnostics, scientists from the University of Melbourne and the Murdoch Children's Research Institute ...

A groundbreaking blood test promises to transform the diagnosis of rare genetic diseases in babies and children, offering results in under three days and potentially eliminating the need for invasive ...